CERMED

Bialystok 15-270

0 studies enrolling now · 2 studies all time

What they study most

Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
• A Phase II Study of M2951 in SLE — Stopped early